Purchase Order 75N90025P00729
- Not listed
- Bionano Genomics, Inc. was awarded a $24,115.32 firm fixed-price purchase order by the National Institutes of Health (NIH) Clinical Center on June 12, 2025, with an ultimate completion date of July 17, 2025. This contract, issued without a small business set-aside designation, represents a direct procurement of genomic research materials or equipment from the San Diego-based manufacturer. The award leverages the company's established expertise in optical genome mapping technology and...
- Bionano Genomics, Inc. has been awarded a firm fixed price purchase order from the Department of Health and Human Services' National Institutes of Health Clinical Center worth $68,747.30 to supply BIONANO PREP SP-G2 BMA 12 GENOME BUNDLE, G3.3 KITS. The kits include consumables to map 12 human genomes and will support the NIH Clinical Center's genomic research efforts. Performance will take place in San Diego, California by March 2024. No subcontractors or set-aside designation were specified....
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $16,875 firm fixed price purchase order to Bionano Genomics, Inc. to deliver NEXUS COPY NUMBER DISCOVERY services for one year. The contract will support the NIH National Human Genome Research Institute's genomic research efforts through Bionano Genomics' single-molecule optical mapping technology, which enables structural variant detection and advanced genome analysis....
- The National Institutes of Health (NIH) Clinical Center awarded a $120,000.00 firm-fixed price purchase order to Bionano Genomics, Inc., a for-profit manufacturer of goods, for the buyout of a proprietary Saphyr System Bionano Optical Genome Mapping (OGM) instrument. This sole-source acquisition is being conducted under the Simplified Acquisition Procedures in Federal Acquisition Regulation (FAR) Part 13, as the total value does not exceed the $250,000.00 Simplified Acquisition Threshold. The...
- This federal contract award is for Bionano Genomics, Inc. to provide a license renewal for the Nexus Copy Number software to the National Human Genome Research Institute (NHGRI). The $16,875 firm fixed-price purchase order supports NHGRI's genomics research initiatives, allowing the agency to analyze genotype data using Bionano's advanced genomic analysis technology. Bionano Genomics is a for-profit manufacturer of scientific instruments and consumables for genetic research, with a history of...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $30,158 firm fixed price purchase order to 10X Genomics, Inc. for 10X Genomics reagents. The place of performance will be 10X Genomics' facilities in Pleasanton, California, with work occurring between July 7, 2023 and September 30, 2023. As the intramural clinical and research program of the NIH, the NIH Clinical Center supports the mission of the NIH to uncover new knowledge that will lead to...
- This firm fixed-price purchase order contract, valued at $56,335.89, was awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and bioinformatics software. The contract is to provide reagents needed for ongoing research by the Critical Care Medicine Department at the NIH. This contract is not set aside and is part of a larger indefinite delivery contract (IDC) valued up to $7,000,000...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a biotechnology company specializing in advanced genomic analysis platforms and reagents. The $22,333.75 contract is for the provision of reagents needed for research by the NIH's Critical Care Medicine Department, with an ultimate completion date of September 30, 2022. 10X Genomics, which is not a small business, has been awarded multiple...
- This firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a life sciences technology company based in Pleasanton, California. The $53,461.29 contract is for the supply of reagents needed for ongoing research by the NIH's Critical Care Medicine Department. The contract has no set-aside designation and is scheduled for completion by July 24, 2025. 10X Genomics is a major provider of advanced genomic analysis...
- The Department of Health and Human Services' National Institutes of Health (NIH) awarded a $46,411.00 firm fixed price purchase order to 10X Genomics, Inc., a small business that specializes in life sciences technology, to provide reagent kits. The award has a completion date of August 21, 2020. 10X Genomics previously held an indefinite delivery contract valued up to $750,000 with the NIH's National Institute of Neurological Disorders and Stroke to supply optimization slides, reagent kits,...
The NIH Clinical Center awarded a $25,624.35 firm fixed price purchase order to Bionano Genomics, Inc. for the procurement of reagents to support optical genome mapping experiments. The contract, which was awarded on September 19, 2025, with an ultimate completion date of September 18, 2026, includes no small business set-aside designation. Bionano Genomics, a San Diego-based manufacturer specializing in advanced genomic analysis solutions, will provide consumable materials and reagents necessary for optical genome mapping research activities conducted at the NIH Clinical Center. Bionano Genomics has established a track record of supporting federal genomic research initiatives through multiple contracts with civilian agencies, including the National Institutes of Health and its various institutes and centers. The company's expertise in optical genome mapping technology and associated consumables positions it to deliver critical research materials that support the NIH Clinical Center's genomic analysis capabilities. This procurement aligns with the NIH's broader mission to advance biomedical research through cutting-edge genomic tools and methodologies used in structural variant detection and genome characterization across various research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.6k | 9/16/25 |